Webinar - Key Changes In Drug Discovery

In this free webinar, the underlying dynamics driving modern drug discovery with selected industry thought leaders will be discussed.
The online discussion panel includes:

• Daniel Erlanson, President (Carmot Therapeutics)
• Jeff Blaney, Director Computational Chemistry & Chemoinformatics (Genentech)
• Henry Johnson, Senior Scientist (Amgen, Onyx Pharmaceuticals subsidiary)
• Mark Gurney, CEO (Tetra Discovery Partners)
• Shirley Louise-May, CDD Advocate (ex-Pfizer)

Register now to reserve your spot in this discussion.

You can read more and share via email or the social media links online here.

Zoe